Type II Secretory Phospholipase A(2) and Prognosis in Patients with Stable Coronary Heart Disease: Mendelian Randomization Study

BACKGROUND: Serum type II secretory phospholipase A(2) (sPLA(2)-IIa) has been found to be predictive of adverse outcomes in patients with stable coronary heart disease. Compounds targeting sPLA(2)-IIa are already under development. This study investigated if an association of sPLA(2)-IIa with second...

Descripción completa

Detalles Bibliográficos
Autores principales: Breitling, Lutz P., Koenig, Wolfgang, Fischer, Marcus, Mallat, Ziad, Hengstenberg, Christian, Rothenbacher, Dietrich, Brenner, Hermann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142130/
https://www.ncbi.nlm.nih.gov/pubmed/21799821
http://dx.doi.org/10.1371/journal.pone.0022318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142130/
https://www.ncbi.nlm.nih.gov/pubmed/21799821
http://dx.doi.org/10.1371/journal.pone.0022318

Ejemplares similares